AAO 2026 – AI and the Business of Retina
Hueyjong Shih, MD Mass Eye and Ear, Boston, MA This session was moderated by Dr. Paul Hahn. How AI is Making Practice More Efficient Dr. Aaron Y. Lee MD, MSCI…
Category: Meeting Coverage
AAO 2026 – Clinical Trial Updates Part III
Emily H. Jung, MD Duke Eye Center, Durham, NC GLOW2 Study: Phase 3 Study of Tarcocimab for Diabetic Retinopathy Margaret A. Chang, MD (Retinal Consultants Medical Group, Sacramento, CA) Dr.…
AAO 2026 – Clinical Trial Updates Part II
Jovany Franco, MD Kellogg Eye Center, University of Michigan, Ann Harbor, MI Subretinal Gene Therapy Laru-zova for X-linked Retinitis Pigmentosa (XLRP): Pivotal VISTA Trial First-time Results Robert Sisk, MD The…
AAO 2026 – Clinical Trial Updates Part I
Jimmy Chen, MD Mass Eye and Ear, Boston, MA The Clinical Trial Updates Part I session at AAO 2026 Retina Subspecialty Day in New Orleans covered durable treatment for neovascular…
Retina Society 2026: Late Breaking Presentation – Phase 2 ArMaDa Results
Eugenia C. Greig, MD Byers Eye Institute Stanford Late Breaking Presentation: Safety and Efficacy of Subretinal OCU410 Gene Therapy for Geographic Atrophy: 12-Month Randomized Phase 2 ArMaDa Results Thursday afternoon…
Retina Society 2026 – Artificial Intelligence Session
Justin C. Muste, Timothy T. Xu, Erik Massenzio, Collin J. Richards Wills Eye Hospital Retinal Aging Clocks Based on Deep Learning Predictions of Age From Retinal Images are Associated…
Retina Society 2026: Schepens Award Lecture: Susan B. Bressler, MD and Neil M. Bressler, MD
Melissa Yuan, MD 2nd year retina fellow, Stanford University Schepens Award Lecture: “The More Things Change, the More They Remain the Same: 40 Years After Starting Retina Fellowship in 1986”…
Retina Society 2026 – AMD 1 Session
Arthur Brant, MD Darius Bordbar, MD Jimmy Chen, MD Massachusetts Eye and Ear Infirmary Thursday’s AMD I session at the Retina Society meeting in Los Angeles was moderated by Carl…